As part of its new cell and gene therapy access tool, HHS’ first focus is improving access to sickle cell disease therapies, which can cost millions of dollars for a one-time dose.
As part of its new cell and gene therapy access tool, HHS’ first focus is improving access to sickle cell disease therapies, which can cost millions of dollars for a one-time dose.
Copyright © 2024 | WordPress Theme by MH Themes
